BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 4019742)

  • 1. Isolation medium for the recovery of Pseudomonas cepacia from respiratory secretions of patients with cystic fibrosis.
    Gilligan PH; Gage PA; Bradshaw LM; Schidlow DV; DeCicco BT
    J Clin Microbiol; 1985 Jul; 22(1):5-8. PubMed ID: 4019742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis.
    Welch DF; Muszynski MJ; Pai CH; Marcon MJ; Hribar MM; Gilligan PH; Matsen JM; Ahlin PA; Hilman BC; Chartrand SA
    J Clin Microbiol; 1987 Sep; 25(9):1730-4. PubMed ID: 3654943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of selective media for isolation of Pseudomonas cepacia from cystic fibrosis patients and environmental sources.
    Carson LA; Tablan OC; Cusick LB; Jarvis WR; Favero MS; Bland LA
    J Clin Microbiol; 1988 Oct; 26(10):2096-100. PubMed ID: 3182996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of selective media for the isolation of yeasts and filamentous fungi from the sputum of adult patients with cystic fibrosis (CF).
    Nagano Y; Millar BC; Goldsmith CE; Walker JM; Elborn JS; Rendall J; Moore JE
    J Cyst Fibros; 2008 Nov; 7(6):566-72. PubMed ID: 18723404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is prolonged incubation required for optimal recovery of Burkholderia cepacia complex in sputum from cystic fibrosis patients? Data versus dogma.
    Naqvi S; Varadhan H; Givney R
    Pathology; 2020 Apr; 52(3):366-369. PubMed ID: 32113671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two selective media developed to isolate Pseudomonas cepacia from patients with cystic fibrosis.
    Black-Payne C; Lierl MB; Bocchini JA; Hilman BC; Rambin ED; Silberman R
    Diagn Microbiol Infect Dis; 1987 Apr; 6(4):277-82. PubMed ID: 3581734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis.
    Tablan OC; Carson LA; Cusick LB; Bland LA; Martone WJ; Jarvis WR
    J Clin Microbiol; 1987 Mar; 25(3):485-7. PubMed ID: 3571451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective media for isolation of Burkholderia (Pseudomonas) cepacia from the respiratory secretions of patients with cystic fibrosis.
    Cimolai N; Trombley C; Davidson AG; Wong LT
    J Clin Pathol; 1995 May; 48(5):488-90. PubMed ID: 7543119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimum use of selective plated media in primary processing of respiratory tract specimens from patients with cystic fibrosis.
    Doern GV; Brogden-Torres B
    J Clin Microbiol; 1992 Oct; 30(10):2740-2. PubMed ID: 1400978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Gram-negative selective agar (GNSA) for the detection of Gram-negative microflora in sputa in patients with cystic fibrosis.
    Moore JE; Xu J; Millar BC; Courtney J; Elborn JS
    J Appl Microbiol; 2003; 95(1):160-6. PubMed ID: 12807467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of isolation media for recovery of Burkholderia cepacia complex from respiratory secretions of patients with cystic fibrosis.
    Henry D; Campbell M; McGimpsey C; Clarke A; Louden L; Burns JL; Roe MH; Vandamme P; Speert D
    J Clin Microbiol; 1999 Apr; 37(4):1004-7. PubMed ID: 10074517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium.
    Henry DA; Campbell ME; LiPuma JJ; Speert DP
    J Clin Microbiol; 1997 Mar; 35(3):614-9. PubMed ID: 9041399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burkholderia (Pseudomonas) cepacia and cystic fibrosis: the epidemiology in Belgium.
    Revets H; Vandamme P; Van Zeebroeck A; De Boeck K; Struelens MJ; Verhaegen J; Ursi JP; Verschraegen G; Franckx H; Malfroot A; Dab I; Lauwers S
    Acta Clin Belg; 1996; 51(4):222-30. PubMed ID: 8858887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved cultural detection of Burkholderia cepacia from sputum in patients with cystic fibrosis.
    Wright RM; Moore JE; Shaw A; Dunbar K; Dodd M; Webb K; Redmond AO; Crowe M; Murphy PG; Peacock S; Elborn JS
    J Clin Pathol; 2001 Oct; 54(10):803-5. PubMed ID: 11577134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of two culture methods for detection of tobramycin-resistant gram-negative organisms in the sputum of patients with cystic fibrosis.
    Van Dalfsen JM; Stapp JR; Phelps C; Stewart P; Burns JL
    J Clin Microbiol; 2002 Jan; 40(1):26-30. PubMed ID: 11773088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis.
    Christenson JC; Welch DF; Mukwaya G; Muszynski MJ; Weaver RE; Brenner DJ
    J Clin Microbiol; 1989 Feb; 27(2):270-3. PubMed ID: 2915020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of selective medium for Burkholderia cepacia isolation in respiratory samples from cystic fibrosis patients.
    da Silva Filho LV; Velloso Lde F; Bento CN; Gytin E; Tateno AF; Levi JE; Rodrigues JC; Ramos SR
    Rev Inst Med Trop Sao Paulo; 2002; 44(4):203-8. PubMed ID: 12219111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel culture medium for isolation of rapidly-growing mycobacteria from the sputum of patients with cystic fibrosis.
    Preece CL; Perry A; Gray B; Kenna DT; Jones AL; Cummings SP; Robb A; Thomas MF; Brodlie M; O'Brien CJ; Bourke SJ; Perry JD
    J Cyst Fibros; 2016 Mar; 15(2):186-91. PubMed ID: 26002312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Various Culture Media for Detection of Rapidly Growing Mycobacteria from Patients with Cystic Fibrosis.
    Preece CL; Wichelhaus TA; Perry A; Jones AL; Cummings SP; Perry JD; Hogardt M
    J Clin Microbiol; 2016 Jul; 54(7):1797-1803. PubMed ID: 27098962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis.
    Kiska DL; Kerr A; Jones MC; Caracciolo JA; Eskridge B; Jordan M; Miller S; Hughes D; King N; Gilligan PH
    J Clin Microbiol; 1996 Apr; 34(4):886-91. PubMed ID: 8815102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.